Radiotherapy Workstation's Algorithms Optimized for IMRT, VMAT Applications

The RayStation includes functionality such as RaySearch Laboratories' (Stockholm, Sweden) algorithms for intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT) optimization, highly accurate dose engines for both photon and proton therapy, and will have full support for four-dimensional (4D) adaptive radiation therapy. The system is built on the latest software architecture and has a graphic user interface offering state-of-the-art usability.

RaySearch Laboratories' business model is based on selling software modules through partnerships with leading medical technology companies. RaySearch's modules are integrated into the partners' systems and the partners have all contacts with the clinics. As a complement to this partner-based business model, RayStation offers the possibility to collaborate directly with a few selected leading research-intensive clinics. This type of collaboration gives RaySearch the freedom to develop innovative solutions directly in a clinical environment, which is a prerequisite for securing the company's position as a leading supplier of advanced radiation therapy software.

In June 2009, a first agreement was signed in Europe with the German clinic Westgerman Protontherapy Center Essen (WPE), where RayStation is planned to be clinically operational in 2010. Receiving 510(k) clearance means that RaySearch can now market RayStation in the United States and enter similar collaboration agreements in that region.

"The fact that we now have our own treatment planning system with FDA [U.S. Food and Drug Administration] clearance is a milestone of strategic importance,” said Johan Löf, CEO of RaySearch. "We have no intentions to go out broadly to a large number of clinics so this does not mean that we alter our business model in a significant way. However, RayStation gives us the possibility to develop the solutions of the future together with some of the world's leading clinics, which is extremely important for us over the long term,” concluded Mr. Löf.

Related Links:
RaySearch Laboratories